Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications
- 1 November 2006
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 6 (11) , 699-709
- https://doi.org/10.1016/s1473-3099(06)70627-2
Abstract
No abstract availableKeywords
This publication has 140 references indexed in Scilit:
- Helicobacter pylori “Test and Treat” or Endoscopy for Managing Dyspepsia: An Individual Patient Data Meta-analysisGastroenterology, 2005
- Identification of a Novel Mutation Affecting Domain V of the 23S rRNA Gene in Helicobacter pyloriHelicobacter, 2004
- Essential Oils as Components of a Diet-Based Approach to Management of Helicobacter InfectionAntimicrobial Agents and Chemotherapy, 2003
- Effects of 16S rRNA Gene Mutations on Tetracycline Resistance in Helicobacter pyloriAntimicrobial Agents and Chemotherapy, 2003
- Alterations in Penicillin-Binding Protein 1A Confer Resistance to β-Lactam Antibiotics in Helicobacter pyloriAntimicrobial Agents and Chemotherapy, 2002
- The CLO test in the UKEuropean Journal of Gastroenterology & Hepatology, 1999
- Stable amoxicillin resistance in Helicobacter pyloriThe Lancet, 1998
- Antimicrobial Activity of RifabutinClinical Infectious Diseases, 1996
- Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infectionThe Lancet, 1995
- Effect of varying pH on the susceptibility ofCampylobacter pylori to antimicrobial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989